Mid-Atlantic Bio

Oct 21, 2009

Presenting Companies Announced for 2009 Mid-Atlantic Bio Conference

Twenty-Four Companies from across the Region Representing Biotech, Biopharmaceutical Drug Development and Discovery, Devices, and Vaccine Sectors

WASHINGTON, October 21, 2009 – Mid-Atlantic Bio today announced nine later-stage growth companies and 15 emerging companies, which will present before an audience of life science investors and industry professionals at the 2009 Mid-Atlantic Bio Conference, November 4 through 6, held in Washington, D.C., at the Washington, DC Convention Center.  The Conference is hosted by the region’s most influential life science and investor associations, the Mid-Atlantic Venture Association (MAVA), the MdBio Division of the Tech Council of Maryland, and the Virginia Biotechnology Association (VaBIO), that are dedicated to promoting the biotechnology industry in the Mid-Atlantic region.

Each year, a limited number of life science companies are invited to present before an audience of capital sources, including venture capitalists, angel investors, and various other qualified financing sources, along with more than 850 conference attendees. For this year’s conference, two distinct tracks will be featured: Showcase (later-stage growth companies) and Growth Watch (emerging companies). 

“In building on last year’s success, we continue to offer a broad platform that encourages investor interest, innovation review, and industry collaboration,” said Host committee member Julia Spicer, executive director, Mid-Atlantic Venture Association (MAVA).  “This year’s lineup includes some of the most outstanding company representatives in a growing, vibrant community in the Mid-Atlantic region.”

Presenting companies were chosen through an industry review process with input from more than 40 investment institutions and industry professionals.

Showcase Track: The later stage companies selected to present in Showcase Track include:

* Arginetix, Inc., Baltimore, Md.
* Cylex, Inc., Columbia, Md.
* Intrexon Corporation, Blacksburg, Va.
* OpGen Inc., Gaithersburg, Md.
* Cardioxyl Pharmaceuticals, Raleigh, N.C.
* HemoShear, Charlottesville, Va.
* OcuCure Therapeutics, Roanoke, Va.
* openQ, Charlottesville, Va.
* Promedior, Melvern, Pa.

Emerging Growth: The emerging companies selected to present in the Growth Watch Track include:

* ADial Pharmaceuticals, Inc., Charlottesville, Va.
* BC Genesis LLC, Blacksburg, Va.
* Celek Pharmaceuticals, Darnestown, Md.
* ContraVac, Inc., Charlottesville, Va.
* Dalos BioPharma, Virginia Beach, Va.
* DioGenix, Gaithersburg, Md.
* EpiEP, Inc., Charlottesville, Va.
* Extinction Pharmaceuticals, Inc., Williamsburg, Va.
* Gliknik Inc., Baltimore, Md.
* Immunomic Therapeutics, Inc., Gaithersburg, Md.
* Inhibikase Therapeutics, Smyrna, Ga.
* Phthisis Diagnostics, Charlottesville, Va.
* Principio Inc., Rockville, Md.
* Profectus BioSciences, Inc., Baltimore, Md.
* Synthonics, Blacksburg, Va.

# # #

ABOUT MID-ATLANTIC BIO

Mid-Atlantic Bio is co-hosted by the MdBio Division of the Tech Council of Maryland (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO).  Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations.  For more information, or to register or sponsor, please visit www.midatlanticbio.org.